Injen RX Pharma Limited
About Injen RX Pharma Limited
Data last updated:
Injen RX Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 15 July 2005.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PLC154829.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹13.71 Lakh. It is led by directors including Devesh Malladi and Rajendra Prabhu Kamalakant.
Its last annual general meeting (AGM) was held on 08 September 2007, and its latest financial statements are for the year ended 31 March 2007. The registered office is at 501 Sentinelhirananadani Gardens Powai, Mumbai, Maharashtra, India – 400076.
Company details
CIN history
Injen RX Pharma has one previous CIN (Corporate Identification Number): U24230MH2005PTC154829. The current CIN is U24230MH2005PLC154829, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2005PLC154829 | Current |
| U24230MH2005PTC154829 | Previous |
Contact details
Injen RX Pharma Limited's registered office is in Mumbai, Maharashtra.
- Registered Address501 Sentinelhirananadani Gardens Powai, Mumbai, Maharashtra, India – 400076
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Injen RX Pharma Limited
FY 2007 filings availableFinancial Statement Summary
| Metrics | FY 2006-07 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2006-07 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Injen RX Pharma Limited, buy the company report.
Board of directors of Injen RX Pharma Limited
Injen RX Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devesh Malladi | Director | 15 Jul 2005 | 21 Years 3 Months | As last reported |
| Rajendra Prabhu Kamalakant | Director | 15 Jul 2006 | 20 Years 3 Months | As last reported |
| Shobna Devesh Malladi | Director | 15 Jul 2005 | 21 Years 3 Months | As last reported |
Legal cases
No court or tribunal cases involving Injen RX Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Injen RX Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Injen RX Pharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Injen RX Pharma Limited has 3 board changes on record since 2005: 3 appointments. The latest: Rajendra Prabhu Kamalakant was appointed as Director on 15 Jul 2006.
Frequently asked questions
Injen RX Pharma is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Injen RX Pharma is a company under liquidation, formerly operating as a public limited company based in Mumbai, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 15 July 2005 and is registered under CIN U24230MH2005PLC154829. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Injen RX Pharma has 3 current directors:
- Devesh Malladi - Director
- Rajendra Prabhu Kamalakant - Director
- Shobna Devesh Malladi - Director
The latest financial statements of Injen RX Pharma on record with the MCA are for the year ended 31 March 2007. Its last annual general meeting was held on 08 September 2007. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Injen RX Pharma is U24230MH2005PLC154829. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Injen RX Pharma was incorporated on 15 July 2005. It is registered with the Registrar of Companies, Mumbai.
Rajendra Prabhu Kamalakant was appointed as Director on 15 Jul 2006. Devesh Malladi was appointed as Director on 15 Jul 2005. Shobna Devesh Malladi was appointed as Director on 15 Jul 2005.
The registered office of Injen RX Pharma is at 501 Sentinelhirananadani Gardens Powai, Mumbai, Maharashtra, India – 400076.
Injen RX Pharma operates in the chemicals industry, in the other chemical product segment.
Injen RX Pharma can be reached at its registered office: 501 Sentinelhirananadani Gardens Powai, Mumbai, Maharashtra, India – 400076.